Perfil
William Edge is an Investment Consultant of NVM.
Mr. Edge is a Director of the Merlin Fund and the Merlin Biosciences Fund.
He served as a Director of Alizyme Plc until April 1, 2009.
Antiguos cargos conocidos de William Edge.
| Empresas | Cargo | Fin |
|---|---|---|
Alizyme Plc
 Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | 01/04/2009 |
NVM Private Equity LLP
 NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Miembro del Comité de Inversión | 30/06/2008 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
NVM Private Equity LLP
NVM Private Equity LLP Investment ManagersFinance NVM Private Equity LLP(NVM Private Equity) is a independent private equity firm founded in 1984. The firm is headquartered in London, the United Kingdom. | Finance |
Alizyme Plc
Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- William Edge
